DEBORAH WHITE: Open Payments
NPI 1477927234 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$472 in 24 payments from 8 companies in 2025. Trend: 2023 $269 · 2024 $459 · 2025 $472
Food & beverage: $472
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $131 |
| ABBVIE INC. | 7 | $122 |
| Vanda Pharmaceuticals Inc. | 2 | $65 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VRAYLAR, REXULTI, FANAPT, UZEDY, ABILIFY ASIMTUFII, INGREZZA, INVEGA SUSTENNA, Auvelity.
Industry payments across MO — which companies pay providers there.
